(Philadelphia, PA) - Glossolalia, otherwise referred to as “speaking in tongues,” has been around for thousands of years, and references to it can be found in the Old and New Testament. Speaking in tongues is an unusual mental state associated with specific religious traditions. The individual appears to be speaking in an incomprehensible language, yet perceives it to have great personal meaning. Now, in a first of its kind study, scientists are shining the light on this mysterious practice -- attempting to explain what actually happens physiologically to the brain of someone while speaking in tongues.

Researchers at the University of Pennsylvania School of Medicine have discovered decreased activity in the frontal lobes, an area of the brain associated with being in control of one’s self. This pioneering study, involving functional imaging of the brain while subjects were speaking in tongues, is in the November issue of Psychiatry Research: Neuroimaging, the official publication of the International Society for Neuroimaging in Psychiatry.

Radiology investigators observed increased or decreased brain activity - by measuring regional cerebral blood flow with SPECT (Single Photon Emission Computed Tomography) imaging - while the subjects were speaking in tongues. They then compared the imaging to what happened to the brain while the subjects sang gospel music.

“We noticed a number of changes that occurred functionally in the brain,” comments Principal Investigator Andrew Newberg, MD, Associate Professor of Radiology, Psychiatry, and Religious Studies, and Director for the Center for Spirituality and the Mind, at Penn. “Our finding of decreased activity in the frontal lobes during the practice of speaking in tongues is fascinating because these subjects truly believe that the spirit of God is moving through them and controlling them to speak. Our brain imaging research shows us that these subjects are not in control of the usual language centers during this activity, which is consistent with their description of a lack of intentional control while speaking in tongues.”

Newberg went on to explain, “These findings could be interpreted as the subject’s sense of self being taken over by something else. We, scientifically, assume it’s being taken over by another part of the brain, but we couldn’t see, in this imaging study, where this took place. We believe this is the first scientific imaging study evaluating changes in cerebral activity -- looking at what actually happens to the brain -- when someone is speaking in tongues. This study also showed a number of other changes in the brain, including those areas involved in emotions and establishing our sense of self.”

Newberg concludes that the changes in the brain during speaking in tongues reflect a complex pattern of brain activity. Newberg suggests that since this is the first study to explore this, future studies will be needed to confirm these findings in an attempt to demystify this fascinating religious phenomenon.

This preliminary study, done only at Penn, examined five subjects in a laboratory setting. The study, set for publication in the November issue of Psychiatry Research: Neuroimaging, can now be accessed on-line at www.sciencedirect.com. The article is titled, “The Measurement of Regional Cerebral Blood Flow During Glossolalia: a Preliminary SPECT Study.” Co-authors include: Nancy Wintering, Donna Morgan, and Mark Waldman.

###

PENN Medicine is a $2.9 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #3 in the nation in U.S.News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals, all of which have received numerous national patient-care honors [Hospital of theUniversity of Pennsylvania; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $425 million awarded in the 2018 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Home Care and Hospice Services, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 40,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2018, Penn Medicine provided more than $525 million to benefit our community.

Share This Page: